Legge K, Min B, Potter N, Zaghouani H
J Exp Med. 1997; 185(6):1043-53.
PMID: 9091578
PMC: 2196232.
DOI: 10.1084/jem.185.6.1043.
An L, Whitton J
J Virol. 1997; 71(3):2292-302.
PMID: 9032365
PMC: 191338.
DOI: 10.1128/JVI.71.3.2292-2302.1997.
Zambidis E, Scott D
Proc Natl Acad Sci U S A. 1996; 93(10):5019-24.
PMID: 8643522
PMC: 39399.
DOI: 10.1073/pnas.93.10.5019.
Brumeanu T, Swiggard W, Steinman R, Bona C, Zaghouani H
J Exp Med. 1993; 178(5):1795-9.
PMID: 8228825
PMC: 2191225.
DOI: 10.1084/jem.178.5.1795.
Fu T, Bonneau R, Tevethia M, Tevethia S
J Virol. 1993; 67(11):6866-71.
PMID: 7692088
PMC: 238134.
DOI: 10.1128/JVI.67.11.6866-6871.1993.
Characterization of a conserved helper-T-cell epitope from group A Streptococcal M proteins.
Robinson J, Case M, Kehoe M
Infect Immun. 1993; 61(3):1062-8.
PMID: 7679372
PMC: 302839.
DOI: 10.1128/iai.61.3.1062-1068.1993.
Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.
Thomson S, Khanna R, Gardner J, Burrows S, Coupar B, Moss D
Proc Natl Acad Sci U S A. 1995; 92(13):5845-9.
PMID: 7541138
PMC: 41598.
DOI: 10.1073/pnas.92.13.5845.
Antiviral protective immunity induced by major histocompatibility complex class I molecule-restricted viral T-lymphocyte epitopes inserted in various positions in immunologically self and nonself proteins.
Weidt G, Deppert W, Buchhop S, Dralle H, Lehmann-Grube F
J Virol. 1995; 69(4):2654-8.
PMID: 7533861
PMC: 188949.
DOI: 10.1128/JVI.69.4.2654-2658.1995.
Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant.
Isobe H, Moran T, Li S, Young A, Nathenson S, Palese P
J Exp Med. 1995; 181(1):203-13.
PMID: 7528768
PMC: 2191835.
DOI: 10.1084/jem.181.1.203.
Differential effects of flanking residues on presentation of epitopes from chimeric peptides.
Bergmann C, Tong L, Cua R, Sensintaffar J, Stohlman S
J Virol. 1994; 68(8):5306-10.
PMID: 7518534
PMC: 236480.
DOI: 10.1128/JVI.68.8.5306-5310.1994.
The cleavage preference of the proteasome governs the yield of antigenic peptides.
Eggers M, Ruppert T, Kloetzel P, Koszinowski U
J Exp Med. 1995; 182(6):1865-70.
PMID: 7500032
PMC: 2192259.
DOI: 10.1084/jem.182.6.1865.
Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes.
Eisenlohr L, Yewdell J, Bennink J
J Exp Med. 1992; 175(2):481-7.
PMID: 1732413
PMC: 2119116.
DOI: 10.1084/jem.175.2.481.
Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.
Falk K, Rotzschke O, Deres K, Metzger J, Jung G, Rammensee H
J Exp Med. 1991; 174(2):425-34.
PMID: 1713253
PMC: 2118916.
DOI: 10.1084/jem.174.2.425.
Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope.
Del Val M, Schlicht H, Volkmer H, Messerle M, Reddehase M, Koszinowski U
J Virol. 1991; 65(7):3641-6.
PMID: 1710286
PMC: 241372.
DOI: 10.1128/JVI.65.7.3641-3646.1991.
Efficient expression of tum- antigen P91A by transfected subgenic fragments.
Chomez P, De Plaen E, Van Pel A, De Smet C, Szikora J, Lurquin C
Immunogenetics. 1992; 35(4):241-52.
PMID: 1541484
DOI: 10.1007/BF00166829.
CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope.
Hahn Y, Hahn C, Braciale V, Braciale T, Rice C
J Exp Med. 1992; 176(5):1335-41.
PMID: 1383384
PMC: 2119416.
DOI: 10.1084/jem.176.5.1335.